Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

NCT00290615 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: cetuximab
DRUG: capecitabine
DRUG: oxaliplatin

Sponsor

Herbert Hurwitz

Collaborators

[object Object]